Hikma Urges Justices To Skip Case On Obviousness Evidence
Hikma Pharmaceuticals and Dr. Reddy's Laboratories Inc. want the U.S. Supreme Court to skip Amarin Pharma's appeal of a decision affirming the invalidation of six patents on its heart drug Vascepa,...To view the full article, register now.
Already a subscriber? Click here to view full article